Federation des caisses Desjardins du Quebec’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-2,435
| Closed | -$8.1K | – | 3003 |
|
|
2025
Q2 | $8.1K | Sell |
2,435
-377
| -13% | -$1.25K | ﹤0.01% | 2115 |
|
|
2025
Q1 | $7.43K | Sell |
2,812
-1,061
| -27% | -$3.13K | ﹤0.01% | 2053 |
|
|
2024
Q4 | $10.3K | Sell |
3,873
-663
| -15% | -$2.16K | ﹤0.01% | 1873 |
|
|
2024
Q3 | $16.9K | Sell |
4,536
-401
| -8% | -$2.04K | ﹤0.01% | 1716 |
|
|
2024
Q2 | $21.5K | Buy |
4,937
+4,911
| +18,888% | +$37.4K | ﹤0.01% | 1602 |
|
|
2024
Q1 | $302 | Sell |
26
-50
| -66% | -$385 | ﹤0.01% | 2279 |
|
|
2023
Q4 | $573 | Sell |
76
-30
| -28% | -$222 | ﹤0.01% | 2190 |
|
|
2023
Q3 | $1.03K | Hold |
106
| – | – | ﹤0.01% | 2149 |
|
|
2023
Q2 | $1.03K | Hold |
106
| – | – | ﹤0.01% | 2129 |
|
|
2023
Q1 | $1.05K | Sell |
106
-1,125
| -91% | -$15K | ﹤0.01% | 2148 |
|
|
2022
Q4 | $14.7K | Sell |
1,231
-61
| -5% | -$904 | ﹤0.01% | 1776 |
|
|
2022
Q3 | $19.8K | Sell |
1,292
-1
| -0.1% | -$19 | ﹤0.01% | 1737 |
|
|
2022
Q2 | $24.1K | Buy |
1,293
+400
| +45% | +$10K | ﹤0.01% | 1699 |
|
|
2022
Q1 | $31.4K | Hold |
893
| – | – | ﹤0.01% | 1708 |
|
|
2021
Q4 | $31.7K | Buy |
893
+300
| +51% | +$15.8K | ﹤0.01% | 1711 |
|
|
2021
Q3 | $45.5K | Sell |
593
-30
| -5% | -$2.13K | ﹤0.01% | 1628 |
|
|
2021
Q2 | $54.4K | Buy |
623
+178
| +40% | +$16.9K | ﹤0.01% | 1584 |
|
|
2021
Q1 | $50.6K | Sell |
445
-20
| -4% | -$2.22K | ﹤0.01% | 1544 |
|
|
2020
Q4 | $19.5K | Buy |
465
+4
| +0.9% | +$148 | ﹤0.01% | 1747 |
|
|
2020
Q3 | $16.1K | Buy |
461
+85
| +23% | +$3.77K | ﹤0.01% | 1554 |
|
|
2020
Q2 | $29.9K | Hold |
376
| – | – | ﹤0.01% | 1343 |
|
|
2020
Q1 | $19.2K | Sell |
376
-1
| -0.3% | -$91 | ﹤0.01% | 1500 |
|
|
2019
Q4 | $34.1K | Buy |
377
+1
| +0.3% | +$93 | ﹤0.01% | 1611 |
|
|
2019
Q3 | $38.8K | Buy |
376
+49
| +15% | +$10.6K | ﹤0.01% | 1525 |
|
|
2019
Q2 | $96.1K | Hold |
327
| – | – | ﹤0.01% | 1318 |
|
|
2019
Q1 | $151K | Hold |
327
| – | – | ﹤0.01% | 1054 |
|
|
2018
Q4 | $95.8K | Sell |
327
-5
| -2% | -$1.2K | ﹤0.01% | 1136 |
|
|
2018
Q3 | $57.7K | Sell |
332
-3
| -0.9% | -$550 | ﹤0.01% | 1308 |
|
|
2018
Q2 | $65K | Sell |
335
-50
| -13% | -$9.22K | ﹤0.01% | 1286 |
|
|
2018
Q1 | $56.2K | Buy |
385
+30
| +8% | +$5.87K | ﹤0.01% | 1294 |
|
|
2017
Q4 | $83.8K | Hold |
355
| – | – | ﹤0.01% | 1207 |
|
|
2017
Q3 | $72K | Sell |
355
-290
| -45% | -$53.4K | ﹤0.01% | 1233 |
|
|
2017
Q2 | $64.1K | Buy |
645
+395
| +158% | +$62.6K | ﹤0.01% | 1331 |
|
|
2017
Q1 | $75.1K | Buy |
+250
| New | +$73.6K | ﹤0.01% | 1077 |
|
Other funds holding CSCI
Federation des caisses Desjardins du Quebec's CSCI Position: Q3 2025 in Review
Federation des caisses Desjardins du Quebec sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q3 2025, closing a stake of 2,435 shares — an estimated $8.1K sold.
Federation des caisses Desjardins du Quebec first reported a position in CSCI in Q1 2017 and held it in 34 quarters. The position peaked at $151K in Q1 2019. 2 funds tracked by Wall St. Rank hold CSCI as of Q3 2025.
- Federation des caisses Desjardins du Quebec reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q3 2025 after selling out during the quarter.
- Federation des caisses Desjardins du Quebec sold 2,435 COSCIENS Biopharma Inc. Common Stock shares in Q3 2025, an estimated $8.1K.
- Federation des caisses Desjardins du Quebec first reported a position in COSCIENS Biopharma Inc. Common Stock in Q1 2017 and held it in 34 quarters.
- Federation des caisses Desjardins du Quebec's COSCIENS Biopharma Inc. Common Stock position peaked at $151K in Q1 2019.
- 2 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q3 2025.
Based on Federation des caisses Desjardins du Quebec's 13F filing for Q3 2025, filed 14 Nov 2025.